Permira has kicked off the week with a public-to-private takeover, agreeing to buy British biopharmaceutical services company Ergomed for £703.1m.
The European private equity house said on 4 September that the cash offer of 1,350p per share marks a 28% premium to Ergomed’s last closing price.